Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The cutaneous T-cell lymphoma clinical trial analysis ...

SHELTON, CT / ACCESS Newswire / May 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...

By Kamal Choudhury and Christy Santhosh May 18 (Reuters) - U.S. President Donald Trump's executive order to accelerate ...

Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...

Adam Fisher, the staff director of the Office of Pharmaceutical Quality in the Center for Drug Evaluation and Research (CDER) ...

The US Food and Drug Administration (FDA) said it is appropriate to use placebo arms in clinical trials when developing drugs to treat endogenous Cushing’s syndrome, despite ethical concerns raised by ...

A partnership between the state of South Carolina, homegrown companies and Medical University of South Carolina is developing a drug to battle COVID-19 and possibly other viral infections. The state ...

When researchers are making a new drug, they face years of work in development and trials. Then, in about 90 per cent of cases, the outcome is a failure and they slide back, snakes-and-ladders style, ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligence ...

Looking back on drug development inputs & services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, ...

On January 7, the FDA made available draft guidance on the development of drugs and biological products for weight reduction within the Center for Drug Evaluation and Research intended for reduction ...